Status:
COMPLETED
Post-approval Study of Percutaneous Left Atrial Appendage Closure ( FLAAC-2 )
Lead Sponsor:
French Cardiology Society
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Patients with atrial fibrillation are at significant risk of thrombus formation in the left atrial appendage, which can lead to a stroke or systemic embolism. This risk justifies first-line prescribin...
Eligibility Criteria
Inclusion
- Any patient for whom an indication has been made for implantation of a device for the closure of the left atrial appendage without restriction of indication and regardless of the outcome of the procedure (implantation success or not).ot).
Exclusion
- Refusal of the patient to participate in this study and therefore the use of his data
- Minor patient
Key Trial Info
Start Date :
July 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 7 2021
Estimated Enrollment :
1051 Patients enrolled
Trial Details
Trial ID
NCT03434015
Start Date
July 9 2018
End Date
October 7 2021
Last Update
September 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henri Mondor Hospital
Créteil, France